Stock Scorecard
Stock Summary for Zoetis Inc - Class A (ZTS) - $127.69 as of 11/26/2025 9:08:28 PM EST
Total Score
13 out of 30
Safety Score
64 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for ZTS
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for ZTS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for ZTS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for ZTS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for ZTS (64 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 5 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Financial Details for ZTS
Company Overview |
|
|---|---|
| Ticker | ZTS |
| Company Name | Zoetis Inc - Class A |
| Country | USA |
| Description | Zoetis Inc. (ZTS) is a leading global animal health company dedicated to improving the health and well-being of livestock and companion animals. As the largest manufacturer of medicines and vaccines for animals, Zoetis leverages advanced research and development to offer a comprehensive range of innovative products that enhance productivity in animal agriculture and support the well-being of pets globally. Committed to sustainability and animal welfare, Zoetis is well-positioned to meet the increasing demand for premium animal health solutions in an expanding market, making it an attractive investment opportunity for institutional investors. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 127.69 |
| Price 4 Years Ago | 234.58 |
| Last Day Price Updated | 11/26/2025 9:08:28 PM EST |
| Last Day Volume | 3,192,282 |
| Average Daily Volume | 4,258,075 |
| 52-Week High | 179.46 |
| 52-Week Low | 115.25 |
| Last Price to 52 Week Low | 10.79% |
Valuation Measures |
|
| Trailing PE | 20.72 |
| Industry PE | 82.60 |
| Sector PE | 88.38 |
| 5-Year Average PE | 34.57 |
| Free Cash Flow Ratio | 27.00 |
| Industry Free Cash Flow Ratio | 12.15 |
| Sector Free Cash Flow Ratio | 28.18 |
| Current Ratio Most Recent Quarter | 3.64 |
| Total Cash Per Share | 4.73 |
| Book Value Per Share Most Recent Quarter | 12.23 |
| Price to Book Ratio | 9.96 |
| Industry Price to Book Ratio | 10.18 |
| Sector Price to Book Ratio | 32.98 |
| Price to Sales Ratio Twelve Trailing Months | 5.79 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.60 |
| Sector Price to Sales Ratio Twelve Trailing Months | 15.65 |
| Analyst Buy Ratings | 8 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 440,693,000 |
| Market Capitalization | 56,272,089,170 |
| Institutional Ownership | 97.22% |
Dividends |
|
| Ex-Dividend Date | 10/31/2025 |
| Previous Dividend Amount | 0.5000 |
| Current Dividend Amount | 0.5000 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 2.00 |
| Trailing Annual Dividend Yield | 1.56% |
| Forward Annual Dividend Rate | 2.00 |
| Forward Annual Dividend Yield | 1.56% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.93% |
| 5-Year Average Dividend Yield | 0.80% |
| 1-Year Dividend Growth Rate Percentage | 15.74% |
| 3-Year Dividend Growth Rate Percentage | 15.47% |
| 5-Year Dividend Growth Rate Percentage | 18.92% |
| All-Time Dividend Growth Rate Percentage | 19.26% |
| Dividend Payout Ratio | 33.73% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 8.50% |
| Annual Earnings Growth | 6.06% |
| Reported EPS 12 Trailing Months | 5.93 |
| Reported EPS Past Year | 4.79 |
| Reported EPS Prior Year | 5.92 |
| Net Income Twelve Trailing Months | 2,651,000,000 |
| Net Income Past Year | 2,486,000,000 |
| Net Income Prior Year | 2,344,000,000 |
| Quarterly Revenue Growth YOY | 0.50% |
| 5-Year Revenue Growth | 8.14% |
| Operating Margin Twelve Trailing Months | 39.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,084,000,000 |
| Total Cash Past Year | 1,985,000,000 |
| Total Cash Prior Year | 2,039,000,000 |
| Net Cash Position Most Recent Quarter | -4,985,000,000 |
| Net Cash Position Past Year | -3,235,000,000 |
| Long Term Debt Past Year | 5,220,000,000 |
| Long Term Debt Prior Year | 6,564,000,000 |
| Total Debt Most Recent Quarter | 7,069,000,000 |
| Equity to Debt Ratio Past Year | 0.48 |
| Equity to Debt Ratio Most Recent Quarter | 0.43 |
| Total Stockholder Equity Past Year | 4,770,000,000 |
| Total Stockholder Equity Prior Year | 4,997,000,000 |
| Total Stockholder Equity Most Recent Quarter | 5,398,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 2,240,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 5.08 |
| Free Cash Flow Past Year | 2,298,000,000 |
| Free Cash Flow Prior Year | 1,621,000,000 |
Options |
|
| Put/Call Ratio | 0.88 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -6.70 |
| MACD Signal | -5.78 |
| 20-Day Bollinger Lower Band | 121.89 |
| 20-Day Bollinger Middle Band | 144.03 |
| 20-Day Bollinger Upper Band | 166.16 |
| Beta | 0.96 |
| RSI | 20.64 |
| 50-Day SMA | 155.29 |
| 150-Day SMA | 167.01 |
| 200-Day SMA | 166.10 |
System |
|
| Modified | 11/25/2025 12:42:50 PM EST |